Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.9K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Ordered Polar Topological Domains Enabling Giant Second-Harmonic Generation in Ferroelectric Nematic Liquid Crystals.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Prioritizing riparian scale landscape management is a spatially efficient strategy for controlling river water quality in China.

Water research·2026
Same author

Rhythmic visual stimulation enhances visual search via occipito-parietal alpha modulation: an electroencephalographic study.

Frontiers in neuroscience·2026
Same author

Feed additives increase soil risk from antibiotic resistance genes via distinct horizontal gene transfer pathways.

Environment international·2026
Same author

Metabolic control of neuroinflammation: focus on itaconate and its derivatives in CNS disorders.

Frontiers in immunology·2026
Same author

Self-buffered epitaxy of barium titanate on oxide insulators enables high-performance electro-optic modulators.

Light, science & applications·2026

Video Experimental Relacionado

Updated: Sep 9, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

MVSGDR: red convolucional de gráficos apilados de múltiples vistas para el reposicionamiento de drogas

Guosheng Gu1, Haowei Wu1, Haojie Han1

  • 1School of Computer Science and Technology, Guangdong University of Technology, Waihuan West Road 100, Guangzhou, 510006 Guangdong, China.

Briefings in bioinformatics
|September 2, 2025
PubMed
Resumen

Este estudio introduce un nuevo marco de reposicionamiento de fármacos (DR), MVSGDR, para mejorar las predicciones de la asociación entre fármacos y enfermedades. MVSGDR mejora efectivamente la representación de características y analiza las relaciones, superando los métodos computacionales existentes.

Palabras clave:
Reposicionamiento de la drogaAsociación entre drogas y enfermedadesred neuronal gráficaAprendizaje de múltiples puntos de vistaMuestreo negativo

Más Videos Relacionados

Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues
07:08

Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues

Published on: July 14, 2015

7.4K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.8K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues
07:08

Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues

Published on: July 14, 2015

7.4K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.8K

Área de la Ciencia:

  • Biología computacional
  • Farmacología
  • Ciencia de las redes

Sus antecedentes:

  • El reposicionamiento de fármacos (DR) es una estrategia de desarrollo de fármacos rentable.
  • Los métodos de DR computacionales actuales luchan por integrar los patrones de la subestructura local con la semántica de la red global.
  • Los métodos existentes a menudo se basan en el aumento de datos para abordar las lagunas de información en las asociaciones entre fármacos y enfermedades (DDA).

Objetivo del estudio:

  • Presentar un nuevo marco de DR, una red convolucional de gráficos apilados de múltiples vistas (MVSGDR), para superar las limitaciones de los enfoques de DR computacionales actuales.
  • Mejorar la precisión de las predicciones de las asociaciones entre fármacos y enfermedades (DDA).

Principales métodos:

  • Desarrolló MVSGDR, un nuevo marco de DR que incorpora tres innovaciones.
  • Módulo apilado de múltiples vistas para la mejora de la función en profundidad a través de la agregación jerárquica de interacciones de vecindad de múltiples saltos.
  • Módulo transformador de subgráficos de dos niveles para el análisis de amplitud de los DDA utilizando subgráficos divididos por METIS.
  • Estrategia de balance de muestreo negativo para mitigar el desequilibrio de la muestra mediante muestras negativas sintéticas.

Principales resultados:

  • MVSGDR demostró un rendimiento superior en extensos experimentos de validación cruzada de 10 veces en cuatro conjuntos de datos de referencia.
  • Se observaron mejoras estadísticamente significativas en comparación con los métodos DR existentes.
  • Los estudios de caso identificaron con éxito DDA no reportadas con evidencia de apoyo de la literatura.

Conclusiones:

  • MVSGDR ofrece un nuevo y poderoso marco para el reposicionamiento de drogas.
  • Los métodos propuestos sinergizan efectivamente los patrones de subestructura localizados con la semántica de la red global.
  • MVSGDR muestra un potencial significativo para identificar nuevas aplicaciones terapéuticas de los fármacos existentes.